Zynex, Inc. (ZYXIQ)

Market Cap	2.07M
Revenue (ttm)	108.20M
Net Income (ttm)	-73.96M
Shares Out	30.39M
EPS (ttm)	-2.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,219,225
Average Volume	4,755,441
Open	0.1450
Previous Close	0.1302
Day's Range	0.0650 - 0.1450
52-Week Range	0.0550 - 8.4500
Beta	1.00
RSI	26.85
Earnings Date	Mar 12, 2026

About Zynex

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1996
• Employees: 1,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: ZYXIQ

Financial Performance

In 2024, Zynex's revenue was $192.35 million, an increase of 4.36% compared to the previous year's $184.32 million. Earnings were $2.99 million, a decrease of -69.24%.